Robert C. Rees

Technology Applications (United States) — United States

Immunology and Microbiology · Life Sciences

43h-index7.4kcitations308works5.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(77), Immune Cell Function and Interaction(42), Virus-based gene therapy research(27), T-cell and B-cell Immunology(26), vaccines and immunoinformatics approaches(23)

Publications306 total

As-Needed Albuterol–Budesonide in Mild Asthma
New England Journal of Medicine·2025· 18 cited
IoT-based Aquaponics Monitoring System
International Journal of Science and Research (IJSR)·2025· 28 citedOpen Access
Road Pothole Detection Using Deep Learning
International Journal of Science and Research (IJSR)·2025Open Access
Emotion Correlation Mining Through Deep Learning
International Journal of Science and Research (IJSR)·2025Open Access
Learning Resource Sharing Platform
International Journal of Science and Research (IJSR)·2025Open Access
Efficacy Of As-needed Albuterol‒Budesonide Versus Albuterol By Baseline Therapy In Participants With Mild Asthma: BATURA Pre-specified Analysis
Journal of Allergy and Clinical Immunology·2025Open Access
Hybrid time series forecasting with conditional restricted Boltzmann machine and quantum neural networks
AIP conference proceedings·2025
Batura: A fully virtual randomized controlled study of as-needed albuterol-budesonide vs albuterol in mild asthma
Annals of Allergy Asthma & Immunology·2024Open Access
A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol–Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design
Journal of Asthma and Allergy·2024· 6 citedOpen Access
Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study
Therapeutic Advances in Respiratory Disease·2024· 6 citedOpen Access
Author response for "Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study"
2023· 1 cited
Evaluation of murine OX40L-murine IgG1(MM1) fusion protein on immunogenicity against L. mexicana infection in BALB/c mice
Comparative Immunology Microbiology and Infectious Diseases·2023
Supplementary Table (S6) from HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis
2023Open Access
Supplementary Table (S4) from HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis
2023Open Access
Supplementary Table (S3) from HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis
2023Open Access
Data from HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis
2023Open Access
Supplementary Table (S1) from HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis
2023Open Access
Supplementary Table (S6) from HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis
2023Open Access
Supplementary Table (S2) from HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis
2023Open Access
Data from HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis
2023Open Access
page 1 of 16Next →

Frequent Co-authors

I G Rennie(9), Graham Ball(9), Karen Sisley(6), Colin S. Creaser(6), Stéphanie McArdle(6), Selman Ali(5), Geng Li(5), Chris M. Bacon(4), M. A. Parsons(4), A. M. Potter(4), J. Alejandro Madrigal(4), David W. Cottam(4), Lee Lancashire(4), A. Graham Pockley(4), Aija Linē(4), Amanda K. Miles(4), I. Anthony Dodi(3), Shahzad I. Mian(3), Janice A. Royds(3), Ian O. Ellis(3)